Cotempla XR-ODT

Drug Neos Therapeutics, LP
Total Payments
$447,045
Transactions
7,723
Doctors
3,562
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $20,693 923 624
2023 $90,158 1,467 824
2022 $40,928 2,670 1,397
2019 $152,550 3 0
2018 $141,701 2,638 1,507
2017 $1,015 22 20

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $257,153 110 57.5%
Food and Beverage $117,497 7,516 26.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $63,210 56 14.1%
Travel and Lodging $5,835 37 1.3%
Consulting Fee $3,350 4 0.7%

Payments by Type

Research
$257,153
110 transactions
General
$189,892
7,613 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A single-dose, two-period, two-treatment, two-way crossover bioequivalence study of two formulations of methylphenidate extended-release orally disintegrating tablets (XR-ODT), 51.8 mg (2 X 25.9 mg) in healthy adults under fasted conditions. Neos Therapeutics, LP $152,550 0
An Open-Label, Single-Dose Pharmacokinetic Study of Cotempla XR ODT in Children 4 to Less Than 6 Years of Age With Attention-Deficit/Hyperactivity Disorder (ADHD) Neos Therapeutics, LP $104,603 0

Top Doctors Receiving Payments for Cotempla XR-ODT

Doctor Specialty Location Total Records
Unknown Atlanta, GA $257,153 110
, M.D Psychiatry Northbrook, IL $45,469 70
, M.D Adolescent Medicine Midlothian, VA $23,585 35
Ann Childress Child & Adolescent Psychiatry Las Vegas, NV $2,100 5
, M.D Psychiatry Baltimore, MD $802.00 36
, CRNP Psychiatric/Mental Health Collegeville, PA $727.38 4
, M.D Psychiatry Houston, TX $637.25 26
, CRNP Pediatrics Millersville, MD $556.67 34
, MD Developmental - Behavioral Pediatrics Orlando, FL $533.61 37
, MD, MPH Psychiatry New Smyrna Beach, FL $455.54 3
, M.D Internal Medicine Charlotte, NC $446.17 6
, ARNP Pediatrics Maitland, FL $441.22 28
, M.D Pediatrics Baltimore, MD $419.90 23
Hannah Church Pediatrics Millersville, MD $419.74 24
, M.D Pediatrics Millersville, MD $356.73 22
, MD Urology New York, NY $349.91 47
, M.D Neurology with Special Qualifications in Child Neurology Morristown, NJ $348.46 34
, M.D Pediatrics Mobile, AL $300.88 29
, CPNP-PC Registered Nurse S Huntington, NY $272.32 36
Derek Ott Los Angeles, CA $268.12 14
, PMHNP-BC Psychiatric/Mental Health Houston, TX $260.02 23
, M.D Child & Adolescent Psychiatry St Petersburg, FL $257.60 3
, MD Neurology with Special Qualifications in Child Neurology Plainview, NY $253.17 20
, PA-C Physician Assistant Houston, TX $251.86 16
, PA Physician Assistant Longview, TX $250.86 16

About Cotempla XR-ODT

Cotempla XR-ODT is a drug associated with $447,045 in payments to 3,562 healthcare providers, recorded across 7,723 transactions in the CMS Open Payments database. The primary manufacturer is Neos Therapeutics, LP.

Payment data is available from 2017 to 2024. In 2024, $20,693 was paid across 923 transactions to 624 doctors.

The most common payment nature for Cotempla XR-ODT is "Unspecified" ($257,153, 57.5% of total).

Cotempla XR-ODT is associated with 2 research studies, including "A single-dose, two-period, two-treatment, two-way crossover bioequivalence study of two formulations of methylphenidate extended-release orally disintegrating tablets (XR-ODT), 51.8 mg (2 X 25.9 mg) in healthy adults under fasted conditions." ($152,550).